GlassScriptPhysician profile
Benjamin Laurence Raymond
NPI 1295105435
$1,392.75
in general payments reported to CMS, 2019-2025
13 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $287 · 2022: $43.39 · 2023: $510 · 2024: $411 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,061.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $408.24 | 2021-2025 | Ozempic |
| Abbvie INC. | $160.27 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $128.70 | 2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.76 | 2022-2024 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $111.11 | 2024 | Rexulti |
| Idorsia Pharmaceuticals US INC | $108.57 | 2023 | Quviviq |
| Axsome Therapeutics, INC. | $97.47 | 2024 | Auvelity |
| Vanda Pharmaceuticals INC. | $96.62 | 2024 | Fanapt |
| Lilly USA, LLC | $80.92 | 2023-2025 | Mounjaro, Zepbound, Emgality |
| Daiichi Sankyo INC. | $25.42 | 2023 | Injectafer |
| Exact Sciences Corporation | $22.14 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $20.73 | 2023 | |
| Glaxosmithkline, LLC. | $18.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Raymond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.